4-(Chloromethyl)-2-isopropylthiazole hydrochloride, 95.0%, 1g

[2-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)phenyl]-morpholin-4-yl-methanone, 98%, 1g

6-Bromo-2H-chromene-3-carboxylic acid, 97.0%, 1g

2-Methyl-1-naphthoic acid, 98.0%, 100mg

4-(3-(4-Hydroxybutyl)-4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile, 95.0%, 250mg

1-Chloro-3-(phenylethynyl)benzene, 97%, 1g

n-Octane, min 99 %, pour la synthèse, 2,5 l, emballage en verre

(E)-ETHYL 3-(4-CYANO-2-NITROPHENYL)ACRYLATE, 90.0%, 1g

Phenoxy-acetic acid hydrazide, 96%, 10g

ETHYL 3,5-DIAMINOBENZOATE, 95.0%, 1g

1,3-Dimethyl 2-(cyclopropylmethyl)propanedioate, 5g

ROTI®Pol Hot-TaqHY, 200 µl, 5 x 40 µl

cis-4-tert-Butylcyclohexanecarboxylic Acid>98.0%(GC)(T)25g